Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.

Saved in:
Bibliographic Details
Title: Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.
Authors: Clarke NW; Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester. Electronic address: noel.clarke@christie.nhs.uk., Ali A; Genito-Urinary Cancer Research Group, Division of Cancer Sciences, The University of Manchester, Manchester., Ingleby FC; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London; London School of Hygiene and Tropical Medicine, London., Hoyle A; Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester., Amos CL; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Attard G; UCL Cancer Institute, London., Brawley CD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Calvert J; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Chowdhury S; Guy's and Saint Thomas' NHS Foundation Trust, London., Cook A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Cross W; St James University Hospital, Leeds., Dearnaley DP; Institute of Cancer Research, Sutton-London., Douis H; Department of Radiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham., Gilbert D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Gillessen S; Division of Cancer Sciences, The University of Manchester, Manchester., Jones RJ; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow., Langley RE; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., MacNair A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Malik Z; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool., Mason MD; Cardiff University, Cardiff., Matheson D; Faculty of Education Health and Wellbeing, University of Wolverhampton, Wolverhampton., Millman R; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Parker CC; Institute of Cancer Research, Sutton-London; Royal Marsden NHS Foundation Trust, London., Ritchie AWS; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Rush H; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Russell JM; Institute of Cancer Sciences, Beatson West of Scotland Cancer Centre, Glasgow., Brown J; University of Sheffield, Sheffield., Beesley S; Kent Oncology Centre, Maidstone., Birtle A; Lancashire Teaching Hospitals NHS Foundation Trust, Preston., Capaldi L; Worcestershire Acute Hospitals NHS Trust, Worcester., Gale J; Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth., Gibbs S; Queen's Hospital, Romford., Lydon A; Torbay and South Devon NHS Foundation Trust, Torbay., Nikapota A; Sussex Cancer Centre, Brighton., Omlin A; Department of Oncology and Haematology, Kantonsspital, St Gallen, Switzerland., O'Sullivan JM; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast., Parikh O; East Lancashire Hospitals NHS Trust, Blackburn., Protheroe A; Oxford University Hospitals NHS Foundation Trust, Oxford., Rudman S; Guy's and Saint Thomas' NHS Foundation Trust, London., Srihari NN; Shrewsbury and Telford Hospital NHS Trust, Shrewsbury., Simms M; Hull and East Yorkshire Hospitals NHS Trust, Hull., Tanguay JS; Velindre Cancer Centre, Cardiff., Tolan S; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool., Wagstaff J; Swansea University College of Medicine, Swansea., Wallace J; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow., Wylie J; The Christie NHS Foundation Trust, Manchester., Zarkar A; Heartlands Hospital, Birmingham., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., James ND; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Dec 01; Vol. 30 (12), pp. 1992-2003.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1569-8041
DOI:10.1093/annonc/mdz396